Home > SOP Information > SOPs and Supporting Information – alphabetic listing > A to B > Analgesic Nephropathy K001 > Rulebase for analgesic nephropathy > Continuous phenacetin consumption

Continuous phenacetin consumption

Analgesic nephropathy - Continuous phenacetin consumption Factor

Last reviewed for CCPS 20 August 2008.

Investigative Documents

Medical Report - Phenacetin - Analgesic Nephropathy [MR9028]

Preliminary questions [39951]

[1]39957

the veteran has consumed an average of at least one gram per day of phenacetin in phenacetin-containing analgesics for a continuous period of at least one year at some time.

[2]39958

the veteran's consumption of an average of at least one gram per day of phenacetin in phenacetin-containing analgesics for a continuous period of at least one year was materially contributed to by treatment of an illness or injury which is identifiable.

39962 — the veteran has established the causal connection between continuous phenacetic consumption and VEA service for the clinical onset of analgesic nephropathy.

39963 — the veteran has established the causal connection between continuous phenacetic consumption and operational service for the clinical onset of analgesic nephropathy.

or

39964 — the veteran has established the causal connection between continuous phenacetic consumption and eligible service for the clinical onset of analgesic nephropathy.

Clinical onset and operational service [39963]

[3]39959

the identified illness or injury made a material contribution to the veteran's consumption of an average of at least one gram per day of phenacetin in phenacetin-containing analgesics for a continuous period of at least one year before the clinical onset of analgesic nephropathy.

39132 — the identified illness or injury, which made a material contribution to the veteran's consumption of phenacetin in phenacetin-containing analgesics, is causally related to operational service. [4] [5]

Clinical onset and eligible service [39964]

[6]39960

the identified illness or injury made a material contribution to the veteran's consumption of an average of at least two grams per day of phenacetin in phenacetin-containing analgesics for a continuous period of at least one year.

[7]39961

the identified illness or injury made a material contribution to the veteran's consumption of an average of at least two grams per day of phenacetin in phenacetin-containing analgesics for a continuous period of at least one year before the clinical onset of analgesic nephropathy. [8]

39133 — the identified illness or injury, which made a material contribution to the veteran's consumption of phenacetin in phenacetin-containing analgesics, is causally related to eligible service. [9] [5]

Source URL (modified on 20/10/2014 - 3:25pm): https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/b/analgesic-nephropathy-k001-n140/rulebase-analgesic-nephropathy/continuous-phenacetin-consumption

Links
[1] https://clik.dva.gov.au/ccpsmedical-193
[2] clikpopup://CCPS/reject39957No
[3] clikpopup://CCPS/reject39958No
[4] clikpopup://CCPS/reject39959No
[5] clikpopup://CCPS/reject39132,39133No
[6] clikpopup://CCPS/Illness contributed to consumption of at least 2g per day of phenacetin for at least 1 year
[7] clikpopup://CCPS/reject39960No
[8] clikpopup://CCPS/reject39961No
[9] clikpopup://CCPS/reject39133No